Ongoing Drug Development to Treat Lyme Disease Driving Global Market Growth

Global Lyme disease treatment market is anticipated to grow at a CAGR of 8.4% during the forecast period (2024-2031). The increased focus of public and private organizations on developing new drugs and devices to diagnose and treat Lyme disease is a key factor driving the global market growth.

Browse the full report description of “Lyme Disease Treatment Market Size, Share & Trends Analysis Report by Administration Route (Oral, Injectable, and Topical), by Treatment (Medication, and Tick Removal), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/lyme-disease-treatment-market

Recent market developments

• In January 2023, Upstate Medical University launched a Multidisciplinary Lyme and Tick-Borne Disease Treatment Center, owing to a $898,000 federal grant from the Health Resources and Services Administration. The center centralized Upstate's existing resources for tick-borne disease prevention.

• In January 2023, Pfizer launched a Phase III clinical trial for a new Lyme disease vaccine, VLA15, developed by Valneva in collaboration with Pfizer. The vaccine, which protects children and adults, is expected to help combat the increasing need for vaccination against the tick-borne disease.

• In February 2023, the US Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation launched Phase 2 of the LymeX Diagnostics Prize, inviting ten Phase 1 winners to participate in a virtual accelerator. The goal is to nurture the development of diagnostics for Food and Drug Administration review. The virtual accelerator provides a pathway to develop the next generation of Lyme disease diagnostics, addressing the significant lag time in detection and treatment interventions due to the current two-tier serological testing system.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Administration Route

o By Treatment

o By Distribution Channel

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., and Pfizer Inc. among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Lyme Disease Treatment Market Report Segment

By Administration Route

• Oral
• Injectable
• Topical 

By Treatment

• Medication
• Tick Removal 

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online

Global Lyme Disease Treatment Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/lyme-disease-treatment-market